POSTOPERATIVE CHEMOTHERAPY FOR PROGNOSTICALLY POOR MAMMARY, BOWEL AND RENAL CARCINOMA

被引：1
|
作者：
BATEMAN, JC
机构：
来源：
SOUTHERN MEDICAL JOURNAL | 1970年 / 63卷 / 06期
关键词：
D O I：
10.1097/00007611-197006000-00022
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：715 / +
页数：1
相关论文
共 50 条
  • [11] COMBINATION CHEMOTHERAPY FOR ADVANCED MAMMARY-CARCINOMA
    WINN, RJ
    OCOHOA, M
    KAUFMAN, RJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1971, 12 (NMAR): : 37 - &
  • [12] Chemotherapy for renal cell carcinoma
    Hartmann, JT
    Bokemeyer, C
    ANTICANCER RESEARCH, 1999, 19 (2C) : 1541 - 1543
  • [13] Chemotherapy for renal cell carcinoma
    Amato, RJ
    SEMINARS IN ONCOLOGY, 2000, 27 (02) : 177 - 186
  • [14] Surgical treatment of mammary carcinomas in dogs with or without postoperative chemotherapy
    Tran, C. M.
    Moore, A. S.
    Frimberger, A. E.
    VETERINARY AND COMPARATIVE ONCOLOGY, 2016, 14 (03) : 252 - 262
  • [15] THROMBOCYTOPENIA IN PATIENTS WITH MAMMARY-CARCINOMA IN THE POSTOPERATIVE PERIOD
    BRITVIN, AA
    ALESHINA, TN
    SHIPULIN, PP
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 1984, 29 (08): : 54 - 55
  • [16] VALENCY OF POSTOPERATIVE RADIOTHERAPY IN THE TREATMENT OF MAMMARY-CARCINOMA
    FROMMHOLD, H
    VATTER, J
    THURN, P
    STRAHLENTHERAPIE, 1981, 157 (03) : 145 - 152
  • [17] VAB-5 COMBINATION CHEMOTHERAPY IN PROGNOSTICALLY POOR RISK PATIENTS WITH GERM-CELL TUMORS
    VUGRIN, D
    WHITMORE, WF
    GOLBEY, RB
    CANCER, 1983, 51 (06) : 1072 - 1075
  • [18] Postoperative Surveillance for Renal Cell Carcinoma
    Merrill, Suzanne B.
    UROLOGIC CLINICS OF NORTH AMERICA, 2017, 44 (02) : 313 - +
  • [19] Mammary Carcinoma Metastasizing to Renal Cell Carcinoma: A Case Report
    Geetha, S.
    Mitchell, F.
    Kashi, M.
    Ort, P.
    Kasturi, D.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2024, 162 : S143 - S143
  • [20] The effect of postoperative adjuvant chemotherapy in gastric carcinoma
    Koo, JY
    Park, SW
    Park, SJ
    Park, BC
    3RD INTERNATIONAL GASTRIC CANCER CONGRESS, 1999, : 743 - 746
12345